The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Laurus Labs receives EIR from USFDA for API facilities
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
KRKA holds 51% and Laurus Labs holds 49% shareholding
The registered capital of the newly founded company is € 50 million
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
